INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M
Data sources
SEC Form 420s ago
House PTR20s ago
SEC 13F6h ago
Robinhood Chain6h ago

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

19,342 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$11K
53 sh
Mar 4, 2026
Page 333 of 484
← PrevNext →
Mar 6, 2026
traded Mar 4, 2026
+2d
SEC Form 4

Evidence

9
LJ
Leite JohnChief Commercial Officer-CLIA
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$185K
5,260 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

9
MA
McGuire AnnieSVP, General Counsel
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$60K
1,664 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

9
MA
McGuire AnnieSVP, General Counsel
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$176K
4,994 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$452K
2,158 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$64K
300 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$67K
300 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$346K
1,645 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$371K
1,782 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$175K
800 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$428K
2,004 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$126K
570 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$110K
500 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$130K
600 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$151K
700 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$73K
350 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$293K
1,412 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$395K
1,871 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$45K
200 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

5
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$216K
1,007 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$194K
900 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
JR
Jain RachitEVP & CFO
SDGRSchrodinger, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
1,631 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

5
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$156K
722 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

1
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$120K
10.0K sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

1
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$61K
5,000 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

1
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$166K
803 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

1
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$105K
496 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

0
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$41K
200 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

46
PM
Paravasthu MukundChief Operating Officer
NVCRNovoCure Ltd
Open-market sale
SELL$596K
43.2K sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

40
KJ
Kroll Lara JSVP & Chief Accounting Officer
CHRDChord Energy Corp
Open-market sale
SELL$568K
5,000 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

40
QA
Quigley AdamChief Financial Officer
SNSharkNinja, Inc.
Open-market sale
SELL$300K
2,620 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

39
WX
Wan XinChief Technology Officer
GCTGigaCloud Technology Inc
Open-market sale
SELL$4.34M
100.0K sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

39
GA
Girdwood AmyChief People & Culture Officer
WBDWarner Bros. Discovery, Inc.
Open-market sale
SELL$2.12M
75.0K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

39
SJ
Shen Zheng JohnDirector
VICRVICOR CORP
Open-market sale
SELL$250K
1,217 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

39
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$2.57M
27.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

39
AP
Aiyar PriyaChief Legal Officer
WBDWarner Bros. Discovery, Inc.
Open-market sale
SELL$6.31M
223.5K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

39
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$1.25M
13.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

39
PM
Paravasthu MukundChief Operating Officer
NVCRNovoCure Ltd
Open-market sale
SELL$72K
5,377 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

39
BC
Brackmann ChristophChief Financial Officer
NVCRNovoCure Ltd
Open-market sale
SELL$85K
6,412 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

38
BW
Bardeen WilliamEVP, Chief Financial Officer
NYTNEW YORK TIMES CO
Open-market sale
SELL$1.03M
13.0K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence